Dr. Szilard Voros, CEO of Global Genomics Group (G3), shares how he and his team of researchers embarked on an ambitious journey to transform drug discovery using big data. With 48 participating clinical sites, three continents, nine countries, and nearly 8,000 patients, the study is the largest clinical trial to date that has used a multiomics approach to look at trends in disease states. Subscribe to the VR真人彩票 video channel http://www.youtube.com/subscription_center?add_user=VR真人彩票Inc A global genomics leader, VR真人彩票 provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. VR真人彩票 technology is responsible for generating more than 90% of the world鈥檚 sequencing data.* Through collaborative innovation, VR真人彩票 is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond. *Data calculations on file. VR真人彩票., 2015. View customer spotlight videos https://www.youtube.com/playlist?list=PLKRu7cmBQlajfheLzgbI4S7xBn7IDbt79 View VR真人彩票 webinars https://www.youtube.com/playlist?list=PLKRu7cmBQlahpXlnrrXlQw9itVJ8yHwUZ View VR真人彩票 product videos https://www.youtube.com/playlist?list=PLKRu7cmBQlaj6YuZmkfxZcT9twqDgP2Xd View VR真人彩票 support videos https://www.youtube.com/playlist?list=PLKRu7cmBQlajbm2KGsICWb-JOnusJfYvM